ERLOCIP ERLOTINIB 150MG TABLETS

Get a Price/Quote

ERLOCIP ERLOTINIB 150MG TABLETS Specification

Origin of Medicine
India

Salt Composition
Erlotinib 150mg

Dosage Form
Oral solid

Pacakaging (Quantity Per Box)
30 Tablets

Drug Type
Allopathic

Ingredients
Erlotinib Hydrochloride

Physical Form
Tablets

Recommended For
Lung and pancreatic cancer patients

Dosage
As directed by physician

Dosage Guidelines
Take with or without food, at the same time each day

Suitable For
Adults

Quantity
30 Tablets per box

Storage Instructions
Store below 30C, protect from light and moisture

ERLOCIP ERLOTINIB 150MG TABLETS Trade Information

Packaging Details
PACK OF 30 TABLETS

About ERLOCIP ERLOTINIB 150MG TABLETS

ERLOCIP 150 MG TABLETS - ERLOTINIB HYDROCHLORIDE

Erlocip Tablets Contains Erlotinib And Its Available As : 100 Mg & 150 Mg Tablets.

Specification :-

Product Name : Erlocip
Content : Erlotinib Hcl
Form : Tablets
Strength : 100 Mg & 150 Mg
Packing : Pack Of 30 Tablets
Manufactured By : Cipla

Note :-Erlocip Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

How Does ERLOCIP ERLOTINIB 150MG Work?

ERLOCIP contains Erlotinib Hydrochloride, which belongs to the class of antineoplastic agents. It functions by blocking specific proteins involved in the growth and spread of cancer cells, particularly in lung and pancreatic cancer. By inhibiting these proteins, ERLOCIP helps slow down or stop cancer cell proliferation, ultimately supporting better disease management as prescribed by your oncologist.

Proper Usage and Administration Guidelines

Take ERLOCIP exactly as directed by your physician, usually once daily at the same time. It may be taken with or without food. Swallow the tablet whole with water; do not crush or split it. Consistent timing daily ensures optimal therapeutic levels. Always follow your oncologists instructions regarding dosage adjustments. For best results, do not miss any doses and keep regular follow-up appointments.

Storage and Shelf Life Information

Store ERLOCIP ERLOTINIB 150MG Tablets below 30C in a dry place, protected from light and moisture. Adhering to proper storage conditions helps maintain the efficacy of the medication. Each box contains 30 tablets, and the product has a shelf life of 24 months from the date of manufacture. Check the expiration date on the packaging before use.

FAQs of ERLOCIP ERLOTINIB 150MG TABLETS:

Q: What are ERLOCIP ERLOTINIB 150MG Tablets used for?

A: ERLOCIP ERLOTINIB 150MG Tablets are indicated for the treatment of certain types of lung and pancreatic cancers in adults. The medication is prescribed to help slow the growth and spread of cancer cells.

Q: How should I take ERLOCIP ERLOTINIB 150MG Tablets?

A: Take this medicine orally once daily, as directed by your physician, at the same time each day. It can be taken with or without food. Swallow the tablet whole with water; do not crush, split, or chew the tablets.

Q: What are the potential side effects of ERLOCIP?

A: Common side effects include skin rash, diarrhea, loss of appetite, and fatigue. If you notice severe side effects or any allergic reactions, inform your doctor immediately for appropriate management.

Q: Who should prescribe ERLOCIP ERLOTINIB 150MG Tablets?

A: This medication should only be prescribed by an oncologist. It is not available for retail sale without a valid prescription from a qualified cancer specialist, as it is intended for specific oncological indications.

Q: How should ERLOCIP be stored and what is its shelf life?

A: Store the tablets below 30C, away from light and moisture, in the original packaging. The medicine has a shelf life of 24 months from its manufacturing date. Always check expiry dates before use.

Q: Can ERLOCIP be used in children or for any other conditions?

A: ERLOCIP is recommended only for adult patients with lung or pancreatic cancer, as prescribed by a healthcare provider. Its safety and efficacy in children or for other diseases have not been established.

Q: What precautions should I follow while using ERLOCIP?

A: Follow your doctors dosage instructions strictly and do not self-adjust your dose. Inform your oncologist about any other medicines you are taking and report any unusual symptoms or severe side effects promptly.

Tell us about your requirement